Best health care companies in Waltham, MA

Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500 Company and a member of the NASDAQ 100 Index, Henry Schein employs nearly 16,000 Team Schein Members and serves more than 775,000 customers. The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries. The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17% since Henry Schein became a public company in 1995.

The Lahey Hospital & Medical Center, formerly known as the Lahey Clinic, is a physician-led nonprofit teaching hospital of Tufts University School of Medicine based in Burlington, Massachusetts. The hospital was founded in Boston in 1923 by surgeon Frank H. Lahey, M.D., and is managed by Beth Israel Lahey Health.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status-an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University's new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients-near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

Olympus Corporation is a Japanese manufacturer of optics and reprography products.

We are bringing our brands together under Bio-Techne. Our current products include the complementary brands, R&D Systems, Tocris, and Novus Biologicals

GO TO . . . COVID-19 Info at Speare Flu Vaccine Clinics Virtual Healthy Aging series Price Transparency Telehealth Visits Online Bill Pay Jobs at Speare Patient Portal Working together to serve the healthcare needs of our patients and community. OUR CE...

Welcome to Emerson Hospital. Located in Concord Massachusetts, Emerson is a full-service, non-profit community hospital known for its outstanding nursing care and specialty patient centers.

Massachusetts Eye and Ear Infirmly is the hospital specializing in research, education and treatment of eye and ear.

Mount Auburn Hospital in Cambridge, Massachusetts, is a teaching hospital of Harvard Medical School.

NaviHealth partners with health plans, health systems and post-acute providers to manage the entire continuum of post-acute care. They utilize evidence-based protocols to optimize care and bundled payment methodologies to align all stakeholders. The result: optimized care and outcomes, reduced inpatient days, reduced hospital readmissions, and increased patient satisfaction.

Since 1978, Care Dimensions has provided comprehensive and compassionate care for individuals and families dealing with life-threatening illnesses. As the non-profit leader in advanced illness care, we offer services in more than 90 communities in East...

Newton-Wellesley Hospital provides the services and expertise of a major medical facility with the convenience and personal attention of a community hospital. The hospital is committed to delivering high-quality, safe and efficient medical care to each and every patient. Newton-Wellesley Hospital is a member of Partners HealthCare, a network founded by Massachusetts General Hospital and Brigham and Women's Hospital. This partners affiliation allows them to provide patients with seamless accessibility to the finest community-based medicine as well as the most advanced specialty care in the world. Through multiple collaborations with Massachusetts General Hospital, MassGeneral Hospital for children and brigham and women's hospital, the hospital offers patients access to various centers of excellence. Patients who come to Newton-Wellesley have access to an excellent medical staff with more than 1,000 affiliated physicians with excellent credentials and the expertise and dedication to provide the highest level of patient care. Their highly skilled, professional nurses deliver quality care with compassion and sensitivity. The nursing staff is made up of qualified experienced individuals who stay current in new techniques through continued education and training. As a result of many updates in technology, the Hospital has made numerous developments and enhancements in health screening, diagnosis and treatment. Newton-Wellesley is committed to providing patients with the most advanced technology and diagnostic services to better meet their health care needs and provide the superb patient care.

SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. With strategic scientific consulting and clinical data services (biostatistics, data management/EDC, and IRT/IWRS) expertise at our core, our services are scalable via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC is The Right Fit For You.

Provides population health management solutions.Telligen is a trusted partner for U.S. government health agencies, state Medicaid agencies, self-funded employer and Taft-Hartley health plans, and managed care organizations, improving health outcomes for millions of people nationwide through proven health management solutions and healthcare expertise.

Fortress Biotech is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Frontier Medicines'is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.

Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.